Home
>
National Drug Code (NDC)
>
Ganirelix Acetate
Ganirelix Acetate - 0052-0301-51 - (Ganirelix Acetate)
Drug Information of Ganirelix Acetate
| Product NDC: | 0052-0301 |
| Proprietary Name: | Ganirelix Acetate |
| Non Proprietary Name: | Ganirelix Acetate |
| Active Ingredient(s): | 250 ug/.5mL & nbsp; Ganirelix Acetate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ganirelix Acetate
| Product NDC: | 0052-0301 |
| Labeler Name: | Organon Pharmaceuticals USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021057 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990729 |
Package Information of Ganirelix Acetate
| Package NDC: | 0052-0301-51 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (0052-0301-51) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS |
NDC Information of Ganirelix Acetate
| NDC Code | 0052-0301-51 |
| Proprietary Name | Ganirelix Acetate |
| Package Description | 1 BLISTER PACK in 1 CARTON (0052-0301-51) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS |
| Product NDC | 0052-0301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ganirelix Acetate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 19990729 |
| Marketing Category Name | NDA |
| Labeler Name | Organon Pharmaceuticals USA |
| Substance Name | GANIRELIX ACETATE |
| Strength Number | 250 |
| Strength Unit | ug/.5mL |
| Pharmaceutical Classes | Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA] |
